A total of 16,755 vaccinators participated in the vaccination process across India, the ministry added. Not a single case of hospitalisation post-vaccine administration has been reported yet

After shooting the weekend special episode with Salman Khan-Weekend Ka Vaar, Pista and a team member met with an accident when their scooter slipped into a ditch

Union Health Minister Dr Harsh Vardhan urged people not to pay heed to rumours and trust only official channels of communication to get correct information about COVID-19

Key to the success of the pan-India COVID-19 vaccination drive, scheduled to be launched by PM Narendra Modi on January 16, will be the cybersecurity framework India has readied, experts say

The pre-prints or preliminary reports of research work related to Covaxin, which are yet to be peer-reviewed are already posted on pre-print servers like bioRxiv, medRxiv and Research Square

The central bank said the statutory inspection of Deutsche Bank's financial position as on March 31, 2019 and the Risk Assessment Report revealed non-compliance with the 'Reserve Bank of India (Interest Rate on Deposits) Directions, 2016'

The Covishield vaccine is being produced in India by the Serum Institute of India at their facility in Pune. For the vaccination drive on January 16, 476 boxes of Covishield vaccine are being supplied out of the Pune Aiport to 13 cities today

Tesla and SpaceX CEO Elon Musk is now the richest person in the world, according to latest data on Bloomberg Billionaires Index; Union Health Minister Dr Harsh Vardhan on Thursday said that the COVID-19 vaccines 'Covishield' and 'Covaxin' are on the verge of being rolled out; Rishad Premji, Chairman of Wipro, has written a letter to his employees thanking them for their contribution and dedication towards the company. Watch this and more on News Blast.Also Read: Bharat Biotech seeks DCGI nod to conduct trials of nasal Covid-19 vaccine

The amount is likely to be disbursed on the basis of beneficiary load on the states. This means states with more healthcare workers registered on Co-WIN platform would get more funds

Private sector willing to support govt in coronavirus vaccine roll-out, says FICCI The private sector is willing to support and augment government's capacity across the value chain of COVID-19 vaccine distribution and administration, industry body FICCI on Thursday said. The FICCI-EY paper, that was developed in consultation with various stakeholders states that India would need 1.3-1.4 lakh vaccination centres, 1 lakh healthcare professionals and 2.0 lakh support staff/ volunteers to suppo...

Dr Krishna Ella, Bharat Biotech chairman spoke to Business Today editor Rajeev Dubey about the efficacy of Covaxin and what makes it safe for use. He said his vaccine was stable and they had data for four months to substantiate the claim. Watch the video for more.

Addressing the media, health ministry secretary Rajesh Bhushan said that \"based on feedback of dry-run\", the government is ready to introduce coronavirus vaccine \"within 10 days from the date of emergency use authorisation

The Prime Minister said this while virtually addressing the crowd at the inauguration of National Atomic Timescale and Bhartiya Nirdeshak Dravya at the National Metrology Conclave

Union Health Minister Dr Harsh Vardhan slammed senior Congress party leaders Shashi Tharoor and Jairam Ramesh, and Samajwadi Party leader Akhilesh Yadav for politicising the 'critical issue'

The ICMR head emphasised that the scientists at ICMR have been successfully able to culture the UK strain and the efficacy of Covaxin against it will be further tested in days to come

Calling it a great day for the country, AIIMS Director Dr Randeep Guleria said that initially Serum-AstraZeneca's Covishield will be administered to the people

India on Sunday granted emergency approval to Bharat Biotech's COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine

COVID-19 vaccine in India: It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, said PM Modi

Covishield has become the first coronavirus vaccine to receive a regulatory nod in India. Now, Drug Controller General of India (DCGI) will take a final call on rolling out the inoculation

CDSCO's expert panel has recommended the Serum Institute of India's Covishield COVID-19 vaccine for emergency use authorisation to DCGI